Molecular Therapy - Nucleic Acids
Open Access
Journal formatting to fit the target journal guidelines
Experts ensure all elements of your paper match journal formatting guidelines to improve publication success rate!
Key Metrics
View Chart Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
DOAJ 
SJR
- PublisherCELL PRESS
- LanguageEnglish
- FrequencyQuarterly
- Article Processing ChargesUSD 3900
- Publication Time20
- Editorial Review ProcessAnonymous peer review
- LanguageEnglish
- Society/Institute/SponsorAmerican Society of Gene & Cell Therapy
- FrequencyQuarterly
- Publication Start Year2012
- Publisher URL
- Website URL
- Publication Time20
- Waiver Policy
- Editorial Team
- Review ProcessAnonymous peer review
- Review Url
- Author instructions
- Deposit PolicySherpa/Romeo
- License typeCC BY, CC BY-NC-ND
- OA statement
Ready to spotlight your research findings?
Impress peers and journals alike with a concise, visual summary of your work.
Meets Top Publisher Standards: Essential for leading journals like Elsevier.Enhances Engagement: Research papers with graphical abstracts receive 3X more downloads and 8X more shares.Tailored Just for You: We’ll create a custom graphical abstract based on your manuscript—no sketches needed.
3000+ graphical abstracts produced with 4.8/5 customer rating | Months | % Papers published |
|---|---|
| 0-3 | 10% |
| 4-6 | 44% |
| 7-9 | 28% |
| >9 | 18% |
Topics Covered
Year-wise Publication
- 5Y
- 10Y
FAQs
Since when has Molecular Therapy - Nucleic Acids been publishing? 
The Molecular Therapy - Nucleic Acids has been publishing since 2012 till date.
How frequently is the Molecular Therapy - Nucleic Acids published?
Molecular Therapy - Nucleic Acids is published Quarterly.
Who is the publisher of Molecular Therapy - Nucleic Acids?
The publisher of Molecular Therapy - Nucleic Acids is CELL PRESS.
How can I view the journal metrics of Molecular Therapy - Nucleic Acids on editage?
For the Molecular Therapy - Nucleic Acids metrics, please refer to the section above on the page.
What is the eISSN and pISSN number of Molecular Therapy - Nucleic Acids?
The eISSN number is 2162-2531 and pISSN number is 2162-2531 for Molecular Therapy - Nucleic Acids.
What is the focus of this journal?
The journal covers a wide range of topics inlcuding Lung, Oligonucleotide, Breast cancer, Skeletal muscle, Lung cancer, Virus, Functional recovery, Hepatocellular carcinoma, Gene expression, RNA-binding protein, Pulmonary hypertension, Myocardial infarction, Extracellular vesicles, Irradiation, Autophagy, Immune cell infiltration, Transcription factor, Colorectal cancer, Subcutaneous injection, Osteosarcoma.
Why is it important to find the right journal for my research?
Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.
Can the choice of journal affect my academic career?
Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.
Is it advisable to target high-impact journals only?
While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.